FIRMQUARRYResearch workspace

GOVERNMENT CONTRACT / PURCHASE ORDER

TO GENERATE A MONOCLONAL ANTIBODY THAT IS SPECIFIC FOR MTORC3 SIGNALING

Awarded to GENSCRIPT USA INC

PIID 75N91021P00769US · USAspendingOther
$28.9K
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation$28,872sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateAug 25, 2021
Company legal name
GENSCRIPT USA INC
UEI / CAGE
KVLBRRAQ6UX1 / Not reported
Parent award
Not reported
Awarding agency
Department of Health and Human Services
Subagency
National Institutes of Health
Industry
Other
NAICS
325413
PSC
6505
Performance period
Not reported — Not reported
Recipient address
860 CENTENNIAL AVE, PISCATAWAY, MIDDLESEX, NJ, 08854
Place of performance
PISCATAWAY, MIDDLESEX, NJ, 08854
Source last modified
Nov 3, 2026

Description

TO GENERATE A MONOCLONAL ANTIBODY THAT IS SPECIFIC FOR MTORC3 SIGNALING

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Award announced

    TO GENERATE A MONOCLONAL ANTIBODY THAT IS SPECIFIC FOR MTORC3 SIGNALING

    US · usaspendingSource ↗
  2. Value increased

    TO GENERATE A MONOCLONAL ANTIBODY THAT IS SPECIFIC FOR MTORC3 SIGNALING

    US · usaspending$28.9KSource ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Aug 25, 20210Not reported$28,872.18Not reportedNot reportedTO GENERATE A MONOCLONAL ANTIBODY THAT IS SPECIFIC FOR MTORC3 SIGNALINGUSAspending ↗